Does ADALIMUMAB Cause Product use in unapproved indication? 3,547 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 3,547 reports of Product use in unapproved indication have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.7% of all adverse event reports for ADALIMUMAB.
3,547
Reports of Product use in unapproved indication with ADALIMUMAB
0.7%
of all ADALIMUMAB reports
1,125
Deaths
1,682
Hospitalizations
How Dangerous Is Product use in unapproved indication From ADALIMUMAB?
Of the 3,547 reports, 1,125 (31.7%) resulted in death, 1,682 (47.4%) required hospitalization, and 1,392 (39.2%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 3,547 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which ADALIMUMAB Alternatives Have Lower Product use in unapproved indication Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB